Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Oramed Pharmaceuticals Inc.

NASDAQ: ORMP · Life Sciences · 4 alerts · CIK 1176309

Share price
$3.90Close, Nov 16
Market cap
$170M
Shares outstanding
43.49MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Oramed Pharmaceuticals Inc. filings on SEC EDGAR ↗

5:23 PM ET 10-Q
Financial Results

Oramed Pharmaceuticals Q3 2026 Results: Net Income $18.4M, Down 62.0% YoY

Oramed Pharmaceuticals reported a significant increase in net income to $134.9 million for the nine months ended September 30, 2026, primarily driven by $180.5 million in financial income. The company's total assets grew to $400.9 million, largely due to substantial increases in the fair value of investments and associates.

Key figure
Net income $18.4M · -62.0% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.